SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-174033
Filing Date
2021-05-27
Accepted
2021-05-26 21:53:59
Documents
4
Effectiveness Date
2021-05-27

Document Format Files

Seq Description Document Type Size
1 S-8 d158930ds8.htm S-8 76940
2 EX-5.1 d158930dex51.htm EX-5.1 9433
3 EX-23.2 d158930dex232.htm EX-23.2 1770
4 GRAPHIC g158930g0526230853148.jpg GRAPHIC 4427
  Complete submission text file 0001193125-21-174033.txt   95543
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256521 | Film No.: 21968348
SIC: 2834 Pharmaceutical Preparations